Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Trazodone HCl New Polymer vs Contramid in Healthy Volunteers
NCT05136521Phase 1Completed
- Sponsor
- Angelini Pharma
- Start
- Feb 2020
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of trazodone in major depressive disorder (MDD) (2 arms), sponsored by Angelini Pharma. Primary endpoints: Maximum Plasma Concentration, Area Under the Curve from time zero to last quantifiable concentration and 1 more. Started Feb 2020; status: completed.
02
Drugs
trazodone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05136521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05136521.